MRTX1133 is a selective non-covalent inhibitor that binds the inactive GDP-bound form of KRAS G12D and has demonstrated potent tumor regression in PDAC mouse xenograft models, including near-complete responses in some cases [8]. The gene discussed is KRAS; the disease is neoplasm.